04:14 PM EST, 02/04/2025 (MT Newswires) -- Amgen ( AMGN ) reported Q4 non-GAAP earnings late Wednesday of $5.31 per diluted share, up from $4.71 a year ago.

Analysts polled by FactSet expected $5.08.

Revenue for the quarter that ended Dec. 31 was $9.09 billion compared with $8.20 billion a year ago.

Analysts expected $8.88 billion.

For 2025, the biotech company is projecting non-GAAP EPS of $20.00 to $21.20 on revenue of $34.3 billion to $35.7 billion.

Analysts are looking for $20.92 and $34.62 billion, respectively.

Amgen ( AMGN ) shares were declining 2% in after-market activity.